In this episode, I break down why their Series B is not just a funding event but a signal of what plans will actually pay for: hard-dollar savings, unreachable-member reachability, and delegated navigation infrastructure.

Key Validation Stats (Havarti)

* 32% reach rate for previously unreachable members

* 22% reduction in ED visits

* 23% reduction in total cost of care

* 3.2× ROI in 12 months (3,000-member claims analysis)

What You’ll Learn

* Why actuarially validated navigation is replacing engagement vendors in 2026

* How REMA targets the #1 cost center Medicaid plans struggle with: unreachable, high-cost, high-churn members

* What the ED suppression → inpatient spillover pathway means for Stars and withholds

* The exact operational mechanics behind REMA’s community-guide model

* How delegated navigation stabilizes the “remnant population” left after redeterminations

* How I think about this model’s procurement lane and fundability

* The 4 states where this model becomes a Stars recovery engine overnight

Resources Mentioned

* Window States

* Foundational Needs Playbook Preview

* 7-Lane Market Map

Timestamps

* 00:00 — Why this raise matters

* 00:28 — Medicaid’s 2026 math (shrinking headcount, rising acuity)

* 00:56 — How REMA’s model actually works

* 01:30 — Havarti’s actuarial findings

* 02:22 — Scorecard + lane placement

* 05:45 — Market expansion & “Window States” lens

* 06:56 — What this means for plans, CBOs, and investors